Genome Medicine

Go back or start search again

Genome Medicine

General information ?

Published by:

BioMed Central

ISSN:

1756-994X

Last checked date:

03/2020

Scope:

Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.

Additional free text:

Co-submissions to other BMC ‘flagship’ journals. If a paper is potentially appropriate in scope for Genome Medicine and Genome Biology or BMC Biology authors have the opportunity to submit a manuscript for joint consideration at two of these journals at the same time. For a paper to be considered as a co-submission, authors should upload their manuscript to one of the two journals and note in their cover letter that they would like a co-consideration with the second journal. Each journal will evaluate the paper independently. If both journals decide to send the paper for review, the editors will select reviewers together for a peer review process that evaluates the manuscript for both journals, and will make independent decisions based on reviewers’ feedback. Website Instructions for authors

Subject?

Main subject area:

Medicine

Breadth of subject area:

Top level subject

Peer review?

Peer review type:

Conventional

Peer review openness:

Closed, single blind

Selectivity:

Selective (IF ~8-15)

Open access?

Free to read option:

Paper can be free for anyone to read

Allows green OA:

Not applicable as gold

Has waivers:

Yes

Has membership system:

Institutional membership

Access type:

Full gold

Licence:

All papers are CC BY

Level of APC:

$2500-4500

Speed?

Speed to first decision:

Unknown

Speed from acceptance to publication:

Unknown

Other?

Ownership of publisher:

Company

Length restrictions:

None

Provides altmetrics:

Altmetric

CrossMark implemented:

Yes

Has a 2015 impact factor:

Yes

Copyedits:

Yes